Table 3

Standardised incidence ratios of cancer for the 1988–2008 time period

Cancer siteObservedExpectedSIR95% CI
All cancer4584311.060.97 to 1.16
Prostate cancer136116.21.170.98 to 1.39
Lung cancer5851.11.130.86 to 1.47
Stomach910.90.820.38 to 1.56
Pancreas68.30.720.26 to 1.57
Colorectal cancer6366.60.950.73 to 1.21
Head and neck*1914.21.340.81 to 2.09
Oral cavity, pharynx and larynx†1813.71.320.78 to 2.08
Larynx54.21.180.38 to 2.77
Melanoma3344.80.740.51 to 1.04
Multiple myeloma961.510.69 to 2.86
Hodgkin disease31.42.080.42 to 6.09
NHL1416.60.850.46 to 1.42
All leukaemia2112.81.641.02 to 2.51
Non-lymphoid leukaemia75.41.290.52 to 2.66
Lymphoid leukaemia147.31.911.04 to 3.20
Connective and soft tissue32.91.040.21 to 3.04
Bone and cartilage20.72.780.31 to 10.0
All other cancers‡8278.61.040.83 to 1.29
  • NHL, non-Hodgkin lymphoma; SIR, standardised incidence ratios.

  • *Excludes cancer of the larynx or oesophagus.

  • †Head and neck without cancer of the lip, sinus cavities, or salivary glands but includes cancer of the larynx.

  • ‡All cancer except; lung, prostate, stomach, pancreas, olon and rectum, oral cavity, pharynx, larynx, melanoma, multiple myeloma, Hodgkin disease, non-Hodgkin lymphoma, and all leukaemia (includes connective and soft tissue).